Clinical evidence of treatment effectiveness
The ultimate goal of anti-HIV therapy is not to influence laboratory values such as viral load and CD4 count, but rather to improve patients’ health and prolong their lives. The adoption of HAART since 1996 has led to a dramatic decline in the number of AIDS-related deaths, at least in industrialised countries where the drugs are widely available. As a consequence, more people are living with HIV and AIDS, and living longer.
latest aidsmap news
- HIV prevalence may decline because the most vulnerable are infected and die first
- Lack of perceived need for HIV treatment associated with poor adherence
- TB doesn't always increase HIV viral load
- New 75mg darunavir tablet approved by FDA for use by HIV-positive children
- Thyroid checks recommended for people with HIV
- Knighthood for head of UK HIV charity
- Gay men often not accessing PEP despite risk of HIV exposure
- Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
- Internalised homophobia leads to sexual risk taking by HIV-positive gay men
- Most gay men willing to consider PrEP for possible HIV exposure